SPRY
ARS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
SPRY Filings
Filing Date
Form Description
Form Type
2026-03-31
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-31 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-24
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-24 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-09
ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-09 · Earnings Call
ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript
2026-03-09
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-03-09 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-03-09
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-09 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-09
Form 8-K - Current report
Key Events
2026-03-09 · Key Events
Form 8-K - Current report
2026-02-13
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-13 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-21
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-21 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-05
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-05 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-05
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-05 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
